Recent studies indicated that NORAD was highly expressed in numerous human cancers, including breast cancer, esophageal squamous cell carcinoma, pancreatic cancer, colorectal cancer, bladder cancer, and cervical cancer, with poor overall survival [34, 48–50]. This evidence concerns the gene NORAD and cervical carcinoma.